Medicann Expands to the UK with Virtual Clinic and E-Pharmacy in England, Wales, Scotland & Northern Ireland

Dr Sunny Nayee, Medical Director at Medicann, is committed to providing a high standard of care for patients as the clinic expands to the UK with a virtual clinic and e-pharmacy.

The Channel Islands' first-ever medicinal cannabis clinic, and multi-award-winning clinic, has announced its expansion into the UK.

Medicann has officially launched its virtual clinic and e-pharmacy across England, Wales, Scotland, and Northern Ireland. Designed to put patients first, the service offers quick access to regulated cannabis-based treatments — with specialist consultations and next-day prescription delivery, all from the comfort of home.

“This isn’t a miracle cure — and we’re always clear about that,” added Gary Whipp, CEO of Medicann. “But it has changed people’s lives. In the Channel Islands, we've seen patients regain their quality of life, return to work, and find relief after years of struggling. That’s why we’re expanding — to bring that same hope and accessibility to patients across the UK.”

With over 50 conditions eligible for treatment, including anxiety, chronic pain, fibromyalgia, insomnia, PTSD, and various neurological disorders, Medicann is redefining how patients receive care in the UK.

“At Medicann, we’re committed to providing a high standard of care where patients feel truly supported,” said Dr. Sunny Nayee, Medical Director at Medicann.

“We also ensure our e-pharmacy is consistently stocked, so patients never have to worry about delays or being let down when they need their medication.”

Why Medicann?

• Over 50 eligible conditions treated – including anxiety, chronic pain, and neurological disorders
• Next-day delivery of prescriptions following online consultation
• Fully remote service with licensed UK clinicians
• EU-GMP approved, MHRA-compliant, and patient-focused

Patient-Centred, Expert-Led

Medicann’s team of licensed clinicians work exclusively through a secure digital platform, offering patients a safe, discreet, and professional alternative to traditional care pathways — with full transparency and ongoing support.

“We’re committed to making safe, regulated medical cannabis accessible to those who need it,” added Dr. Nayee. “It’s about meeting patients with convenience, compassion, and clinical integrity.”